A new study reveals that a common blood pressure medication may significantly reduce the risk of developing dementia in patients with type 2 diabetes. Researchers found that those taking the drug showed a marked decline in cognitive decline over time compared to peers not on the treatment. The findings suggest potential implications for preventing neurodegenerative diseases in high-risk populations, though experts emphasize the need for further validation. The study highlights a promising avenue for medical intervention in an area where prevention options remain limited.